Stifel Financial Corp trimmed its holdings in shares of Agilent Technologies Inc (NYSE:A) by 1.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,073 shares of the medical research company’s stock after selling 1,426 shares during the quarter. Stifel Financial Corp’s holdings in Agilent Technologies were worth $5,332,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in the company. Vanguard Group Inc raised its stake in shares of Agilent Technologies by 0.8% during the 3rd quarter. Vanguard Group Inc now owns 24,155,483 shares of the medical research company’s stock worth $1,703,929,000 after buying an additional 194,607 shares during the period. OppenheimerFunds Inc. raised its stake in shares of Agilent Technologies by 12.5% during the 3rd quarter. OppenheimerFunds Inc. now owns 8,590,725 shares of the medical research company’s stock worth $605,989,000 after buying an additional 954,104 shares during the period. Northern Trust Corp raised its stake in shares of Agilent Technologies by 2.0% during the 4th quarter. Northern Trust Corp now owns 3,807,998 shares of the medical research company’s stock worth $256,888,000 after buying an additional 75,416 shares during the period. Findlay Park Partners LLP acquired a new position in shares of Agilent Technologies during the 4th quarter worth approximately $246,229,000. Finally, Cantillon Capital Management LLC raised its stake in shares of Agilent Technologies by 0.7% during the 4th quarter. Cantillon Capital Management LLC now owns 3,557,589 shares of the medical research company’s stock worth $239,994,000 after buying an additional 24,411 shares during the period.
Several research analysts have recently weighed in on the company. UBS Group assumed coverage on Agilent Technologies in a research note on Friday, March 15th. They set a “buy” rating and a $92.00 target price for the company. Needham & Company LLC reissued a “buy” rating and issued a $88.00 price objective (up from $77.00) on shares of Agilent Technologies in a research note on Monday, February 25th. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $88.00 price objective for the company in a research note on Friday, February 22nd. Janney Montgomery Scott reissued a “buy” rating and issued a $90.00 price objective (up from $80.00) on shares of Agilent Technologies in a research note on Thursday, February 21st. Finally, Bank of America reissued a “buy” rating and issued a $87.00 price objective (up from $78.00) on shares of Agilent Technologies in a research note on Thursday, February 21st. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $86.91.
NYSE A opened at $78.99 on Friday. Agilent Technologies Inc has a one year low of $60.42 and a one year high of $82.27. The company has a debt-to-equity ratio of 0.36, a current ratio of 3.39 and a quick ratio of 2.79. The firm has a market capitalization of $26.04 billion, a P/E ratio of 28.37, a PEG ratio of 2.28 and a beta of 1.38.
Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 20th. The medical research company reported $0.76 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.73 by $0.03. Agilent Technologies had a return on equity of 19.90% and a net margin of 22.86%. The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the prior year, the company earned $0.66 EPS. The firm’s revenue was up 6.0% compared to the same quarter last year. On average, sell-side analysts forecast that Agilent Technologies Inc will post 3.06 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 24th. Shareholders of record on Tuesday, April 2nd will be paid a $0.164 dividend. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date is Monday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.66%.
In other Agilent Technologies news, CEO Michael R. Mcmullen sold 17,491 shares of the firm’s stock in a transaction on Wednesday, January 30th. The stock was sold at an average price of $75.00, for a total value of $1,311,825.00. Following the completion of the sale, the chief executive officer now directly owns 456,430 shares of the company’s stock, valued at approximately $34,232,250. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Rodney Gonsalves sold 6,155 shares of the firm’s stock in a transaction on Wednesday, March 6th. The stock was sold at an average price of $79.79, for a total value of $491,107.45. The disclosure for this sale can be found here. Insiders sold a total of 74,171 shares of company stock valued at $5,764,185 over the last ninety days.
ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Highlight Press and is owned by of Highlight Press. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://highlightpress.com/2019/03/23/agilent-technologies-inc-a-shares-sold-by-stifel-financial-corp.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Featured Story: Why do companies pay special dividends?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.